NCT06951737

Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibrillation Recurrence In Diabetic Patients

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 120 (actual)
• Sponsor: Bursa Postgraduate Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

Consecutive DCCV was performed until to achieve 120 patients in SR (60 DM patients who used SGLT-2 inhibitors and 60 DM patients who did not use SGLT-2 inhibitors). Patients defined as SGLT-2 inhibitor user group and control group. The two groups were monitored for AF recurrence on the first day, then at one, three, and six months after CV.

Conditions

• Diabetes Mellitus
• Atrial Fibrillation (AF)

Timeline

• Start date: 2022-10-02
• Primary completion: 2024-04-02
• Completion: 2024-10-02
• First posted: 2025-04-30
• Last updated: 2025-06-03

Locations

1 site across 1 country: Turkey (Türkiye)